Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. The company is headquartered in Eden Prairie, Minnesota and currently employs 389 full-time employees. The company also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Follow-Up Questions
Who is the CEO of Surmodics Inc?
Mr. Gary Maharaj is the President of Surmodics Inc, joining the firm since 2010.
What is the price performance of SRDX stock?
The current price of SRDX is $32.34, it has decreased 0.08% in the last trading day.
What are the primary business themes or industries for Surmodics Inc?
Surmodics Inc belongs to Health Care industry and the sector is Health Care
What is Surmodics Inc market cap?
Surmodics Inc's current market cap is $462.4M
Is Surmodics Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Surmodics Inc, including 0 strong buy, 0 buy, 4 hold, 1 sell, and 0 strong sell
